IL121349A0 - Delivery of substances to injured site of the central nervous system - Google Patents

Delivery of substances to injured site of the central nervous system

Info

Publication number
IL121349A0
IL121349A0 IL12134997A IL12134997A IL121349A0 IL 121349 A0 IL121349 A0 IL 121349A0 IL 12134997 A IL12134997 A IL 12134997A IL 12134997 A IL12134997 A IL 12134997A IL 121349 A0 IL121349 A0 IL 121349A0
Authority
IL
Israel
Prior art keywords
substances
delivery
nervous system
central nervous
injured site
Prior art date
Application number
IL12134997A
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL12134997A priority Critical patent/IL121349A0/en
Publication of IL121349A0 publication Critical patent/IL121349A0/en
Priority to IL12455098A priority patent/IL124550A0/en
Priority to IL13415998A priority patent/IL134159A0/en
Priority to AU85717/98A priority patent/AU755872B2/en
Priority to CA002296999A priority patent/CA2296999A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46432—Nervous system antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
IL12134997A 1997-07-21 1997-07-21 Delivery of substances to injured site of the central nervous system IL121349A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL12134997A IL121349A0 (en) 1997-07-21 1997-07-21 Delivery of substances to injured site of the central nervous system
IL12455098A IL124550A0 (en) 1997-07-21 1998-05-19 Compositions comprising activated t-cells or t-cell activating agents and their use
IL13415998A IL134159A0 (en) 1997-07-21 1998-07-21 Activated t-cells and their uses
AU85717/98A AU755872B2 (en) 1997-07-21 1998-07-21 Activated T-cells and their uses
CA002296999A CA2296999A1 (en) 1997-07-21 1998-07-21 Activated t-cells and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12134997A IL121349A0 (en) 1997-07-21 1997-07-21 Delivery of substances to injured site of the central nervous system

Publications (1)

Publication Number Publication Date
IL121349A0 true IL121349A0 (en) 1998-01-04

Family

ID=11070411

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12134997A IL121349A0 (en) 1997-07-21 1997-07-21 Delivery of substances to injured site of the central nervous system

Country Status (3)

Country Link
AU (1) AU755872B2 (en)
CA (1) CA2296999A1 (en)
IL (1) IL121349A0 (en)

Also Published As

Publication number Publication date
CA2296999A1 (en) 1999-07-15
AU755872B2 (en) 2003-01-02
AU8571798A (en) 1999-07-26

Similar Documents

Publication Publication Date Title
EG24144A (en) Disubstituted bicyclic heterocycles their preparation and their use as medicaments
EP0654973A4 (en) System of drug delivery to the lymphatic tissues.
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
HUP9901454A3 (en) Dosage form of ibuprofen
ZA987551B (en) Solid pharmaceutical dosage forms
ZA988030B (en) Fracture healing using pthrp analogs
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
EP1036573A4 (en) Device for delivering drug through skin or mucosa
EP0941039A4 (en) Transdermal administration of ment
HK1020523A1 (en) Uniform drug delivery therapy
ZA983169B (en) Pharmaceutical dosage units
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
HU9603206D0 (en) Transdermal delivery of anti-epileptic drugs
GB9601186D0 (en) Administration of Drugs
HUP0100105A3 (en) Application of tnf antagonists as medicaments for treating septic diseases
AU2193797A (en) Delivery of therapeutic agents to the prostate
EP0913159A4 (en) Drug delivery system using galactoxyloglucan
IL121349A0 (en) Delivery of substances to injured site of the central nervous system
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
IL126671A0 (en) Drug preferably for inhibiting inflammation
IL116324A0 (en) Delivery of substances to injured site of the central nervous system
GB9605726D0 (en) Delivery of drugs etc
GB9705835D0 (en) Delivery of drugs etc
PL316463A1 (en) Novel therapeutic pharmaceutical composition
TW323512U (en) Improved structure of therapeutic traction device